No profile data available.
Jyong Biotech Ltd. (MENS) is a healthcare company in the urinary system treatment drugs industry, based in New Taipei City, Taiwan, with about 27 full-time employees.
It reported revenue of $0 for fiscal year 2024, and net income of -$3.02 million. Its market capitalization was $159.66 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
, a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia.
Jyong Biotech reported $0 in revenue for fiscal year 2024.
$159.66 million as of October 9, 2026.
Listed companies of a similar size in the same industry (urinary system treatment drugs) include Vera Therapeutics, Inc. (VERA), ProKidney Corp. (PROK), Akebia Therapeutics, Inc. (AKBA), Unicycive Therapeutics, Inc. (UNCY).